PomDoctor Ltd Reports Revenue Growth Amid Market Weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 09 Dec 25
Source: Business Insider
PomDoctor Ltd's stock fell by 7.54% and crossed below the 5-day SMA amid a mixed market environment.
The company reported a 16.2% net revenue growth in the first half of fiscal 2025, driven by a significant surge in its online pharmacy segment. This growth reflects successful market expansion strategies despite intense competition.
The implications of this revenue growth are positive for PomDoctor Ltd, as it indicates effective operational optimization and cost control measures, positioning the company well for future growth.
Analyst Views on POM
About POM
PomDoctor Ltd is a holding company principally engaged in operating a online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment mainly engaged in providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment mainly engaged in pharmacy retail sales and wholesale. The Company mainly operates its businesses in the domestic market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
